There are many reasons why mesothelioma patients might want to enroll in a clinical trial. Clinical trials offer patients a chance to try out new medicines and treatments for the disease, as well as contribute vital data needed to further research mesothelioma so that one day a cure may be found.
There are different types of clinical trials for mesothelioma: ones which are centered on treating the existing disease, either with new drugs or other medical treatments; ones which look at ways to prevent people from getting mesothelioma; trials which aim to improve the diagnosis process for mesothelioma; and trials which aim to improve the quality of life for patients with untreatable mesothelioma.
There are usually three phases to a clinical trial: the first is testing on humans rather than animals; the second is generally about assessing dosage or the efficacy of a medicine or treatment; and the third is a much bigger trial needed for the FDA to approve the drug or treatment for widespread use. Find out more about clinical testing for mesothelioma and how you can get involved here.
Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.